Toxoplasmic retinochoroiditis in an Italian referral center

European Journal of Ophthalmology

Volumn 19, Issue 5, 2009, Pages 824-830

  Accorinti, Massimo ^a   Bruscolini, Alice ^a   Pirraglia, Maria Pia ^a   Liverani, Marco ^a   Caggiano, Claudio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Epidemiology; Toxoplasmic infection; Toxoplasmic retinochoroiditis

Indexed keywords

ANTIVIRUS AGENT; AZITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; IMMUNOSUPPRESSIVE AGENT; PYRIMETHAMINE; STEROID; SULFALENE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN CALCIFICATION; CARDIOVASCULAR DISEASE; CHILD; CHORIORETINITIS; CONTROLLED STUDY; CONVULSION; DYSLEXIA; FEMALE; HUMAN; IRIDOCYCLITIS; ITALY; MAJOR CLINICAL STUDY; MALE; MYOPIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; RETINA DETACHMENT; STRABISMUS; TOXOPLASMOSIS; UVEITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHORIORETINITIS; FEMALE; HUMANS; INFANT; ITALY; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TIME FACTORS; TOXOPLASMOSIS, OCULAR; YOUNG ADULT;

EID: 70549102150     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900522     Document Type: Article

References (38)

1. Gilbert RE, Stanford MR, Jackson H, Holliman RE, Sanders MD. Incidence of acute symptomatic toxoplasma retinochoraiditis in south London according to country of birth. BMJ 1995; 310: 1037-40.
2. Päivönsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand 2000; 78: 84-8.
3. Perkins ES. Ocular toxoplasmosis. Br J Ophthalmol 1973; 57: 1-17.
4. Perkins ES. Uveitis and Toxoplasmosis. 1st ed. Churchill: London, 1961; 93-6.
5. Rothova A. Ocular, involvement in toxoplasmosis. Br J Ophthalmol 1993; 77: 371.
6. Holland GN, O' Condor GR, Belfort R, Rimington JS. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis, MO: Mosby; 1996: 1183-223.
7. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 2003; 136: 973-88.
8. Pavesio CE, Lightman S. Toxoplasma gondii and ocular toxoplasmosis pathogenesis. Br J Ophthalmol 1996; 80: 1099-107.
9. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992; 114: 136-44.
10. Silveira C, Belfort R, Muccioli C, et al. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol 2001; 131: 351-4.
11. Holland GN. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 1999; 128: 502-5.
12. Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol 2000; 84: 224-6.
13. Akstein RB, Wilson LA, Teutsch SM. Acquired texoplasmosis. Ophthalmology 1982; 89: 1299-302.
14. Rothova A, Meenken C, Buitenhuis HJ, et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol 1993; 115: 517-23.
15. Soheilian M, Sadoughi MM, Ghajarnia M, et al. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology 2005; 112: 1876-82.
16. Pivetti Pezzi P, Accorinti M, Tamburi S, Ciapparoni V, Abdulaziz MA. Clinical features of toxoplasmic retinochoroiditis in patients with acquired immunodeficiency syndrome. Ann Ophthalmol 1994; 26: 73-84.
17. Tabbara KF, Nussenblatt R. Posterior uveitis: Diagnosis and Management. Boston: Butterworth-Heinemann, 1994; 53-60.
18. McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 1996; 121: 35-46.
19. Pivetti Pezzi P. Uveiti. Milan: Masson, 1996; 108-14.
20. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996; 114: 593-9.
21. Pivetti-Pezzi P, Accorinti M, La Cava M, Colabelli Gisoldi RA, Abdulaziz MA. Endogenous uveitis: an analysis of 1,417 cases. Ophthalmologica 1996; 210: 234-8.
22. Islam SM, Tabbara KF. Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol 2002; 9: 239-49.
23. Wakefield D, Dunlop I, McCluskey PJ, Penny R. Uveitis: aetiology and disease associations in an Australian population. Aust NZ J Ophthalmol 1986; 14: 181-7.
24. Mets MB, Holfer E, Boyer KM, Swisher CN. Eye manifestation of congenital toxoplasmosis. Am J Ophthalmol 1996; 122: 309.
25. Peyron F, Wallon M, Bernardoux C. Long-term follow-up of patients with congenital ocular toxoplasmosis. N Engl J Med 1996; 334: 993-4.
26. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Br J Ophthalmol 1973; 1-57.
27. Tabbara K, Hyndiuk RA. Infections of the Eye. Little Brown: Boston, 1996; 659-72.
28. Hogan MJ, Kimura SJ, O'Connor GR. Ocular toxoplasmosis. Arch Ophthalmol 1964; 72: 592-600.
29. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002; 109: 869-78.
30. Frenkel JK. Toxoplasma gondii in cats: fecal stages identified by as coccidian oocysts: Science 1970; 167: 893-6
31. Culbertson WW, Tabbara KF, O'Connor R. Experimental ocular toxoplasmosis in primates. Arch Ophthalmol 1982; 100: 321-3.
32. Newman PE, Ghosheh R, Tabbara KF, O'Connor GR, Stern W. The role of hypersensitivity reactions to toxoplasma antigens in experimental ocular toxoplasmosis in nonhuman primates. Am J Ophthalmol 1982; 94: 159-64.
33. De Abreu MT, Belfort R Jr, Hirata PS. Fuchs' heterochromic cyclitis and ocular toxoplasmosis. Am J Ophthalmol 1982; 93: 739-44.
34. O' Connor GR. Factors related to the initiation and recurrence of uveitis. XL Edward Jackson Memorial Lecture. Am J Ophthalmol 1983; 96: 577-99.
35. Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol 1969; 81: 481-93.
36. Canamucio CJ, Hallett JW, Leopold IH. Recurrence of treated toxoplasmic uveitis. Am J Ophthalmol 1963; 55: 1035-39.
37. Holland GN, Crespi, MG, Dam-Van Loon NT, et al. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am J Ophthalmol 2008; 145: 1007-13.
38. Silveira C, Belfort R Jr, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002; 134: 41-6.